OC 36 - Venous Thromboembolism Risk Prediction in Cancer Patients

Moderator(s)

• 

  Tzu-Fei Wang, MD, MPH (she/her/hers)

  Associate professor
  Internal Medicine
  Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada
  Ottawa, Ontario, Canada
• 

  Alok Khorana, MD (he/him/his)

  Professor of Medicine
  Cleveland Clinic and Case Comprehensive Cancer Center
  Cleveland, Ohio, United States

Presentations:

• 10:45 – 11:00 ET

  External validation of novel electronic health record (EHR) risk model for cancer associated thrombosis in a comprehensive cancer center
  

  Presenting Author: Ang Li, MD, MS – Section of Hematology-Oncology, Baylor College of Medicine

  Co-Author: Giordana De Las Pozas – MD Anderson Cancer Center

  Co-Author: Clark Andersen – MD Anderson Cancer Center

  Co-Author: Chijioke Nze – MD Anderson Cancer Center

  Co-Author: Katy Toale – MD Anderson Cancer Center

  Co-Author: Emily Milner – Baylor College of Medicine

  Co-Author: Nathanael Fillmore – VA Boston Healthcare System, Harvard Medical School

  Co-Author: Elizabeth Yu Chiao – MD Anderson Cancer Center

  Co-Author: Cristhiam Rojas Hernandez – MD Anderson Cancer Center

  Co-Author: Michael H. Kroll – MD Anderson Cancer Center

  Co-Author: Kelly Merriman – MD Anderson Cancer Center

  Co-Author: Christopher Flowers – MD Anderson Cancer Center
• 11:00 – 11:15 ET

  Machine-learning based risk prediction of cancer associated thrombosis: internal, external, and pre-clinical validation studies
  

  Presenting Author: Rushad Patell, MD (he/him/his) – Beth Israel Deaconess Medical Center, Boston, MA, USA

  Co-Author: Dimitra Karagkouni – Beth Israel Deaconess Medical Center

  Co-Author: Marisa Brake – Beth Israel Deaconess Medical Center

  Co-Author: Anna Falanga, MD (she/her/hers) – Department of Immunohematology and Transfusion Medicine, Papa Giovanni XXIII Hospital, Bergamo, Italy

  Co-Author: Marina Marchetti, PhD (she/her/hers) – Department of Immunohematology and Transfusion Medicine, Papa Giovanni XXIII Hospital, Bergamo, Italy

  Co-Author: Laura Russo – Department of Immunohematology and Transfusion Medicine, Papa Giovanni XXIII Hospital, Bergamo, Italy

  Co-Author: Simon Mantha, MD, MPH – Memorial Sloan Kettering Cancer Center

  Co-Author: Marc Carrier, MD – Ottawa Hospital Research Institute, Ottawa, ON, Canada

  Co-Author: Philip S. Wells – Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada.

  Co-Author: Donna Neuberg – Dana Farber

  Co-Author: Siyang Ren – Dana Farber

  Co-Author: Robert Flaumenhaft – Beth Israel Deaconess Medical Center

  Co-Author: Ioannis Vlachos – Beth Israel Deaconess Medical Center

  Co-Author: Sol Schulman, MD, PhD (he/him/his) – Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Boston, MA

  Co-Author: Jeffrey I. Zwicker, MD – Department of Medicine, Hematology Service, Memorial Sloan Kettering Cancer Center, New York City, NY
• 11:15 – 11:30 ET

  Epidemiologic Risk Predictors of Venous Thromboembolism (VTE) among Cancer Patients Treated at U.S. Veterans Affairs (VA) Healthcare System
  

  Presenting Author: Kylee Martens, MD (she/her/hers) – Oregon Health & Science University

  Co-Author: Ang Li, MD, MS – Section of Hematology-Oncology, Baylor College of Medicine

  Co-Author: Jennifer La – U.S. Department of Veterans Affairs

  Co-Author: Sarah May – Baylor College of Medicine

  Co-Author: Nhan V Do – Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC)

  Co-Author: Mary T Brophy – Boston University; VA Boston Healthcare System

  Co-Author: J. Michael Gaziano – Boston University Chobanian & Avedisian School of Medicine

  Co-Author: Saran Lotfollahzadeh – Renal and Vascular Research Section, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA

  Co-Author: Vipul Chitalia – Renal Section, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA,Veterans Affairs Boston Healthcare System, Boston MA 02118, USA, Institute of Medical Engineering and Sciences, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA

  Co-Author: Katya Ravid – Department of Medicine and Whitaker Cardiovascular Institute, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA

  Co-Author: Nathanael Fillmore – VA Boston Healthcare System, Harvard Medical School
• 11:30 – 11:45 ET

  External validation of the IMPEDE VTE score for predicting venous thromboembolism in patients with newly diagnosed multiple myeloma receiving immunomodulatory drugs: a retrospective cohort study
  

  Co-Author: Benjamin Crichi – AP.HP Nord Université Paris Cité

  Co-Author: David Crichi – AP.HP Nord Université Paris Cité

  Co-Author: Stéphanie Harel – AP.HP Nord Université Paris Cité

  Co-Author: Bruno Royer – AP.HP Nord Université Paris Cité

  Presenting Author: Corinne Frere, MD, PhD (she/her/hers) – AP.HP Sorbonne Université

  Co-Author: Laure Deville – AP.HP Nord Université Paris Cité
• 11:45 – 12:00 ET

  Predictive factors of venous thromboembolism events in multiple myeloma: a French cohort from 2012 to 2021.
  

  Presenting Author: Sara Boukhlal, MD – Internal Medicine, Brest University Hospital

  Co-Author: Emmanuelle Le Moigne – Internal Medicine, Brest University Hospital

  Co-Author: Francis Couturaud, PhD (he/him/his) – Centre Hospitalo-Universitaire de Brest, Département de Médecine Interne et Pneumologie, INSERM U1304, CIC INSERM 1412, Univ_Brest, Brest, FCRIN INNOVTE, France.

  Co-Author: Jean-Richard Eveillard – Hematology, Brest University Hospital